[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methanol | CAS:118175-10-3

We serve [4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methanol CAS:118175-10-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methanol

Chemical Name:[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methanol
CAS.NO:118175-10-3
Synonyms:[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methanol
(4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methanol
2-Hydroxymethyl-3-methyl-4-(3-methoxypropanoxyl)pyridine
2-HYDROXYMETHYL-4-METHOXYPROPOXY-3-METHYLPYRIDINE
2-Hydroxymethyl-4-(3-methoxypropoxy)-3-methylpyridine
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 342.8±37.0 °C at 760 mmHg
Molecular Formula C11H17NO3
Molecular Weight 211.258
Flash Point 161.1±26.5 °C
 
Specification:
Appearance:Off-white crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Rabeprazole(CAS:117976-89-3).



Contact us for information like [4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Hydroxymethyl-4-(3-methoxypropoxy)-3-methylpyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Hydroxymethyl-4-(3-methoxypropoxy)-3-methylpyridine Use and application,(4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methanol technical grade,usp/ep/jp grade.


Related News: In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.1-(3-methylpyrazin-2-yl)ethanone manufacturer The Philippines reported its first Wuhan coronavirus fatality on Sunday.chloromethyl carbonochloridate supplier Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.Oxirane vendor Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.